Literature DB >> 875133

Transcription of the genome of adenovirus type 12. IV. Maps of stable late RNA from productively infected human cells.

K H Scheidtmann, W Doerfler.   

Abstract

From human KB cells productively infected with adenovirus type 12, mRNA and stable nuclear RNA were isolated late (42 h) after infection. Using restriction endonuclease fragments of adenovirus type 12 DNA, mRNA and stable nuclear RNA sequences were mapped on the viral genome. Late after infection, preferentially the r (= rightward) strand is transcribed into stable nuclear RNA, whereas the l (= leftward) strand is expressed only to a minor extent. Adenovirus type 12-specific mRNA originates from the following sections on the viral genome: 0 to 0.11, 0.18 to 0.20, 0.27 to 0.49, 0.56 to 0.63, 0.68 to 0.84, and 0.89 to 0.92 fractional length units on the r strand and 0.11 to 0.16, 0.22 to 0.27, 0.50 to 0.54, 0.62 to 0.66, 0.855 to 0.865, and 0.93 to 1.0 fractional length units on the l strand. Self-complementary viral RNA isolated at 42 h postinfection anneals to 70 to 80% of each strand of the viral genome.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 875133      PMCID: PMC515756     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  Propagation in a fluid medium of a human epidermoid carcinoma, strain KB.

Authors:  H EAGLE
Journal:  Proc Soc Exp Biol Med       Date:  1955-07

2.  RNA synthesis and processing in adenovirus-infected cells.

Authors:  L Philipson; U Pettersson; U Lindberg; C Tibbetts; B Vennström; T Persson
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

3.  RNA transcription in cultures productively infected with adenovirus 2.

Authors:  E A Craig; J Tal; T Nishimoto; S Zimmer; M McGrogan; H J Raskas
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

4.  Transcription of the genome of adenovirus type 12. III. Maps of stable RNA from productively infected human cells and abortively infected and transformed hamster cells.

Authors:  J Ortin; K H Scheidtmann; R Greenberg; M Westphal; W Doerfler
Journal:  J Virol       Date:  1976-11       Impact factor: 5.103

5.  The response of BHK21 cells to infection with type 12 adenovirus. VI. Synthesis of virus-specific RNA.

Authors:  K Raska; W A Strohl
Journal:  Virology       Date:  1972-03       Impact factor: 3.616

6.  Synthesis of complementary RNA sequences during productive adenovirus infection.

Authors:  U Pettersson; L Philipson
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

7.  Synthesis of virus-specific ribonucleic acid in KB cells infected with type 2 adenovirus.

Authors:  J J Lucas; H S Ginsberg
Journal:  J Virol       Date:  1971-08       Impact factor: 5.103

8.  Preparation, molecular weight, base composition, and secondary structure of giant nuclear ribonucleic acid.

Authors:  D S Holmes; J Bonner
Journal:  Biochemistry       Date:  1973-06-05       Impact factor: 3.162

9.  Cell-free synthesis of adenovirus 2 proteins programmed by fractionated messenger RNA: a comparison of polypeptide products and messenger RNA lengths.

Authors:  C W Anderson; J B Lewis; J F Atkins; R F Gesteland
Journal:  Proc Natl Acad Sci U S A       Date:  1974-07       Impact factor: 11.205

10.  Intracellular forms of adenovirus DNA. V. Viral DNA sequences in hamster cells abortively infected and transformed with human adenovirus type 12.

Authors:  E Fanning; W Doerfler
Journal:  J Virol       Date:  1976-11       Impact factor: 5.103

View more
  3 in total

1.  Transcription map for adenovirus type 12 DNA.

Authors:  J R Smiley; S Mak
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

2.  Comparison of late mRNA splicing among class B and class C adenoviruses.

Authors:  B A Kilpatrick; R E Gelinas; T R Broker; L T Chow
Journal:  J Virol       Date:  1979-06       Impact factor: 5.103

3.  Adenovirus type 12-induced rat tumor cells of neuroepithelial origin: persistence and expression of the viral genome.

Authors:  H Ibelgaufts; W Doerfler; K H Scheidtmann; W Wechsler
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.